Journal of Lipid Research, Vol 34, 377-395, Copyright © 1993 by Lipid Research, Inc.

ARTICLES

Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta- tigogenin cellobioside (CP-88818; tiqueside)

HJ Harwood Jr, CE Chandler, LD Pellarin, FW Bangerter, RW Wilkins, CA Long, PG Cosgrove, MR Malinow, CA Marzetta and JL Pettini
Department of Metabolic Diseases and Exploratory Toxicology, Pfizer Central Research, Pfizer, Inc., Groton, CT 06340.

Natural and synthetic saponins inhibit cholesterol absorption and reduce plasma cholesterol levels in experimental animals and are therefore of potential pharmacologic utility in the treatment of hypercholesterolemia. To determine the effects of this class of compounds on cholesterol absorption and metabolism, we evaluated the effects of the synthetic saponin, beta-tigogenin cellobioside (tiqueside; CP-88818), on male golden Syrian hamsters. When administered as either a single oral bolus or as a dietary supplement for up to 2 weeks, tiqueside inhibited cholesterol absorption in a dose- dependent manner in both the presence and absence of dietary cholesterol. Administration of tiqueside to chow-fed hamsters as a 0.2% dietary supplement (150 mg/kg per day) for 4 days resulted in a 68% decrease in intestinal cholesterol absorption with no change in either bile absorption or cholesterol 7 alpha-hydroxylase activity, suggesting that tiqueside inhibits cholesterol absorption without interfering with enterohepatic bile acid recirculation. Under these conditions, hepatic cholesterol levels were also reduced in a dose-dependent manner. Hepatic cholesterol reduction was highly correlated with cholesterol absorption inhibition, and induced compensatory increases in both hepatic HMG-CoA reductase activity and hepatic low density lipoprotein (LDL) receptor levels. Compensatory increases in intestinal HMG-CoA reductase activity were also noted after tiqueside administration, and are consistent with a luminal mechanism for tiqueside action. As a consequence of these changes to cholesterol metabolism, tiqueside administration induced plasma cholesterol reductions that were highly correlated with both hepatic cholesterol reduction and cholesterol absorption inhibition. Tiqueside also produced comparable plasma cholesterol lowering in a variety of other species fed either cholesterol-free diets (hamster, rat, mouse, dog) or cholesterol- containing diets (hamster, rat, rabbit, mouse, cynomolgus monkey, rhesus monkey, SEA quail) indicating the ubiquity of tiqueside action. For all species evaluated except the dog, the reduction in plasma cholesterol was due primarily to a reduction in circulating non-HDL cholesterol levels with little or no change in HDL cholesterol levels. Taken together, these results indicate that inhibition of cholesterol absorption by tiqueside produces profound effects on cholesterol metabolism without affecting bile acid metabolism, and that these changes lead to reductions primarily in plasma non-HDL cholesterol concentrations. The synthetic saponin, tiqueside, may thus represent a prototypical form of therapy for the treatment of hypercholesterolemia.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. P. Visavadiya and A. V. R. L. Narasimhacharya Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats Evid. Based Complement. Altern. Med., August 27, 2007; (2007) nem091v1. [Abstract] [Full Text] [PDF]

				W. Kramer, F. Girbig, D. Corsiero, A. Pfenninger, W. Frick, G. Jahne, M. Rhein, W. Wendler, F. Lottspeich, E. O. Hochleitner, et al. Aminopeptidase N (CD13) Is a Molecular Target of the Cholesterol Absorption Inhibitor Ezetimibe in the Enterocyte Brush Border Membrane J. Biol. Chem., January 14, 2005; 280(2): 1306 - 1320. [Abstract] [Full Text] [PDF]

				C. E. Chandler, D. E. Wilder, J. L. Pettini, Y. E. Savoy, S. F. Petras, G. Chang, J. Vincent, and H. J. Harwood Jr. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans J. Lipid Res., October 1, 2003; 44(10): 1887 - 1901. [Abstract] [Full Text] [PDF]

				L. A. Woollett, D. D. Buckley, L. Yao, P. J. H. Jones, N. A. Granholm, E. A. Tolley, and J. E. Heubi Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans J. Lipid Res., May 1, 2003; 44(5): 935 - 942. [Abstract] [Full Text] [PDF]

				J. Y. L. Chiang Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors Endocr. Rev., August 1, 2002; 23(4): 443 - 463. [Abstract] [Full Text] [PDF]

				H. Matsuura Saponins in Garlic as Modifiers of the Risk of Cardiovascular Disease J. Nutr., March 1, 2001; 131(3): 1000S - 1005. [Abstract] [Full Text]

				J. Férézou, M. Combettes-Souverain, M. Souidi, J. L. Smith, N. Boehler, F. Milliat, E. Eckhardt, G. Blanchard, M. Riottot, C. Sérougne, et al. Cholesterol, bile acid, and lipoprotein metabolism in two strains of hamster, one resistant, the other sensitive (LPN) to sucrose-induced cholelithiasis J. Lipid Res., December 1, 2000; 41(12): 2042 - 2054. [Abstract] [Full Text]

				C. P. Sparrow, S. Patel, J. Baffic, Y.-S. Chao, M. Hernandez, M.-H. Lam, J. Montenegro, S. D. Wright, and P. A. Detmers A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro J. Lipid Res., October 1, 1999; 40(10): 1747 - 1757. [Abstract] [Full Text]

				Y. Nakamura, Y. Tsumura, Y. Tonogai, and T. Shibata Fecal Steroid Excretion Is Increased in Rats by Oral Administration of Gymnemic Acids Contained in Gymnema sylvestre Leaves J. Nutr., June 1, 1999; 129(6): 1214 - 1222. [Abstract] [Full Text]

				L. A. Morehouse, F.-W. Bangerter, M. P. DeNinno, P. B. Inskeep, P. A. McCarthy, J. L. Pettini, Y. E. Savoy, E. D. Sugarman, R. W. Wilkins, T. C. Wilson, et al. Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action J. Lipid Res., March 1, 1999; 40(3): 464 - 474. [Abstract] [Full Text]

				A. Tall, C. Welch, D. Applebaum-Bowden, and M. Wassef Interaction of Diet and Genes in Atherogenesis Report of an NHLBI Working Group Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3326 - 3331. [Abstract] [Full Text]